Trial
NCT02323100
Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Jewish Health
Collaborators
University of Alabama at Birmingham; Children's Hospital of Philadelphia; Johns Hopkins University; Horizon Pharma Ireland, Ltd., Dublin Ireland
Condition
Cystic Fibrosis
Intervention
Ravicti low dose
Why stopped
funding ended
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-17